<VariationArchive RecordType="classified" VariationID="981470" VariationName="NM_001466.4(FZD2):c.367_388dup (p.Phe130fs)" VariationType="Duplication" Accession="VCV000981470" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2021-04-02" MostRecentSubmission="2021-04-02">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="969557" VariationID="981470">
      <GeneList>
        <Gene Symbol="FZD2" FullName="frizzled class receptor 2" GeneID="2535" HGNC_ID="HGNC:4040" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44557484" stop="44561262" display_start="44557484" display_stop="44561262" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42634811" stop="42638629" display_start="42634811" display_stop="42638629" Strand="+" />
          </Location>
          <OMIM>600667</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001466.4(FZD2):c.367_388dup (p.Phe130fs)</Name>
      <CanonicalSPDI>NC_000017.11:44558054:GCCCTCATGAACAAGTTCGGTT:GCCCTCATGAACAAGTTCGGTTGCCCTCATGAACAAGTTCGGTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17q21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44558054" stop="44558055" display_start="44558054" display_stop="44558055" variantLength="22" positionVCF="44558054" referenceAlleleVCF="A" alternateAlleleVCF="AGCCCTCATGAACAAGTTCGGTT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42635422" stop="42635423" display_start="42635422" display_stop="42635423" variantLength="22" positionVCF="42635422" referenceAlleleVCF="A" alternateAlleleVCF="AGCCCTCATGAACAAGTTCGGTT" />
      </Location>
      <ProteinChange>F130fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.42635423_42635444dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.42635423_42635444dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.44558055_44558076dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.44558055_44558076dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001466.4" sequenceAccession="NM_001466" sequenceVersion="4" change="c.367_388dup" MANESelect="true">
            <Expression>NM_001466.4:c.367_388dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001457.1" sequenceAccession="NP_001457" sequenceVersion="1" change="p.Phe130fs">
            <Expression>NP_001457.1:p.Phe130fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2144572390" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001466.4(FZD2):c.367_388dup (p.Phe130fs) AND Autosomal dominant Robinow syndrome 1" Accession="RCV001353075" Version="1">
        <ClassifiedConditionList TraitSetID="7220">
          <ClassifiedCondition DB="MedGen" ID="C4551475">Autosomal dominant Robinow syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-05-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-04-02" MostRecentSubmission="2021-04-02">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="7220" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4113" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Covesdem syndrome (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Costovertebral segmentation defect with mesomelia (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant Robinow syndrome 1</ElementValue>
                <XRef ID="MONDO:0024455" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Robinow dwarfism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fetal face syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acral dysostosis with facial and genital abnormalities</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">WNT5A-Related Robinow Syndrome, Autosomal Dominant</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DRS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DRS1</ElementValue>
                <XRef Type="MIM" ID="180700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2013" />
                <XRef ID="2013" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Autosomal dominant Robinow syndrome (ADRS) is characterized by skeletal findings (short stature, mesomelic limb shortening predominantly of the upper limbs, and brachydactyly), genital abnormalities (in males: micropenis / webbed penis, hypoplastic scrotum, cryptorchidism; in females: hypoplastic clitoris and labia majora), dysmorphic facial features (widely spaced and prominent eyes, frontal bossing, anteverted nares, midface retrusion), dental abnormalities (including malocclusion, crowding, hypodontia, late eruption of permanent teeth), bilobed tongue, and occasional prenatal macrocephaly that persists postnatally. Less common findings include renal anomalies, radial head dislocation, vertebral abnormalities such as hemivertebrae and scoliosis, nail dysplasia, cardiac defects, cleft lip/palate, and (rarely) cognitive delay. When present, cardiac defects are a major cause of morbidity and mortality. A variant of Robinow syndrome, associated with osteosclerosis and caused by a heterozygous pathogenic variant in DVL1, is characterized by normal stature, persistent macrocephaly, increased bone mineral density with skull osteosclerosis, and hearing loss, in addition to the typical features described above.</Attribute>
                <XRef ID="NBK268648" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25577943</ID>
                <ID Source="BookShelf">NBK268648</ID>
              </Citation>
              <XRef ID="3107" DB="Orphanet" />
              <XRef ID="97360" DB="Orphanet" />
              <XRef ID="C4551475" DB="MedGen" />
              <XRef ID="MONDO:0024455" DB="MONDO" />
              <XRef Type="MIM" ID="180700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2839998" SubmissionDate="2020-09-30" DateLastUpdated="2021-04-02" DateCreated="2021-04-02">
        <ClinVarSubmissionID localKey="NM_001466.3; exon1; c.367_388dup; p.Phe130Cysfs*98|OMIM:180700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001438009" DateUpdated="2021-04-02" DateCreated="2021-04-02" Type="SCV" Version="1" SubmitterName="Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine" OrgID="505572" OrganizationCategory="laboratory" OrgAbbreviation="BHCMG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>research</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Sanger sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Robinow syndrome</ElementValue>
                </Name>
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FZD2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001466.3:c.367_388dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="180700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8238617</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2839998" TraitType="Finding" MappingType="Name" MappingValue="Robinow syndrome" MappingRef="Preferred">
        <MedGen CUI="C0265205" Name="Robinow syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2839998" TraitType="Disease" MappingType="XRef" MappingValue="180700" MappingRef="OMIM">
        <MedGen CUI="C4551475" Name="Autosomal dominant Robinow syndrome 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

